|
|
Volumn 93, Issue 1, 2015, Pages 7-8
|
|
The race against time
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHAD3 PROTEIN;
EBOLA VACCINE;
GSK NIAID VACCINE;
RECOMBINANT VESICULAR STOMATITIS VIRUS VACCINE;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
RECOMBINANT VACCINE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EBOLA HEMORRHAGIC FEVER;
EBOLA VIRUS;
HUMAN;
NONHUMAN;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT RESPONSE;
VACCINATION;
VESICULOVIRUS;
WORLD HEALTH ORGANIZATION;
HEALTH;
MEDICAL RESEARCH;
ORGANIZATION AND MANAGEMENT;
TIME FACTOR;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS, PHASE I AS TOPIC;
EBOLA VACCINES;
GLOBAL HEALTH;
HUMANS;
TIME FACTORS;
VACCINES, SYNTHETIC;
WORLD HEALTH ORGANIZATION;
|
|
EID: 84920094446
PISSN: 00429686
EISSN: 15640604
Source Type: Journal
DOI: 10.2471/BLT.15.020115 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|